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Abstract. Leukocyte recruitment is a key step in the in- 
flammatory reaction. Several changes in the cell mor- 
phology take place during lymphocyte activation and 
migration: spheric-shaped resting T cells become polar- 
ized during activation, developing a well defined cyto- 
plasmic projection designated as cellular uropod. We 
found that the chemotactic and proinflammatory 
chemokines RANTES, MCP-1, and, to a lower extent, 
MIP-la, MIP-113, and IL-8, were able to induce uropod 
formation and ICAM-3 redistribution in T lympho- 
blasts adhered to ICAM-1 or VCAM-1. A similar 
chemokine-mediated effect was observed during T cells 
binding to the fibronectin fragments of 38- and 80-kD, 
that contain the binding sites for the integrins VLA-4 
and VLA-5, respectively. The uropod structure concen- 
trated the ICAM-3 adhesion molecule (a ligand for 
LFA-1), and emerged to the outer milieu from the area 
of contact between lymphocyte and protein ligands. In 
addition, we found that other adhesion molecules such 
as ICAM-1, CD43, and CD44, also redistributed to the 
lymphocyte uropod upon RANTES stimulation, 
whereas a wide number of other cell surface receptors 
did not redistribute. Chemokines displayed a selective 
effect among different T cell subsets; MIP-1[3 had more 
potent action on CD8 ÷ T cells and tumor infiltrating 
lymphocytes (TIL), whereas RANTES and MIP-let tar- 
geted selectively CD4  ÷ T cells. We have also examined 
the involvement of cAMP signaling pathway in uropod 
formation. Interestingly, several cAMP agonists were 
able to induce uropod formation and ICAM-3 redistri- 
bution, whereas H-89, a specific inhibitor of the cAMP- 
dependent protein kinase, abrogated the chemokine- 
mediated uropod formation, thus pointing out a role for 
cAMP-dependent signaling in the development of this 
cytoplasmic projection. Since the lymphocyte uropod 
induced by chemokines was completely abrogated by 
Bordetella pertussis toxin, the formation of this mem- 
brane projection appears to be dependent on G pro- 
teins signaling pathways. In addition, the involvement 
of myosin-based cytoskeleton in uropod formation and 
ICAM-3 redistribution in response to chemokines was 
suggested by the prevention of this phenomenon with 
the myosin-disrupting agent butanedione monoxime. 
Interestingly, this agent also inhibited the ICAM-3- 
mediated cell aggregation, but not the cell adhesion to 
substrata. Altogether, these results demonstrate that 
uropod formation and adhesion receptor redistribution 
is a novel function mediated by chemokines; this phe- 
nomenon may represent a mechanism that significantly 
contributes to the recruitment of circulating leukocytes 
to inflammatory  loci. 
important process  in the inflammatory response is 
the recruitment of leukocytes into tissue. This phe- 
nomenon is regulated by a cascade  of molecular 
events which involve the adhesion of leukocytes to endo- 
thelium followed by their migration into tissue  (Butcher, 
1991; Springer,  1994). Initially, selectin-mediated interac- 
tions cause  leukocytes to roll over the endothelial cells, 
where they contact factors that, through the activation of 
leukocyte integrins, trigger strong adhesion (arrest) to en- 
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dothelium. Thereafter, migration into tissue is directed by 
locally active promigratory factors. Although the adhesion 
molecules  involved  in the recruitment of leukocytes into 
tissues  are well defined, less is known about the factors 
that trigger the adhesion and that direct extravasation of 
the inflammatory  cells (Butcher, 1991; Springer, 1994). 
It has recently been proposed that the chemokines or 
chemoattractive cytokines, trigger adhesion and migration 
of distinct leukocyte subsets either as soluble chemoattrac- 
tants or as immobilized molecules bound to proteoglycans 
of the endothelial surface (Oppenheim et al., 1991; Schall, 
1991; Miller  and Krangel, 1992; Huber et al., 1991; and 
Tanaka et al., 1993a). Chemokines are a family of 70-80 aa 
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four conserved cysteine residues. They have been grouped 
into two subfamilies, the a- or "C-X-C" subfamily that in- 
cludes interleukin (IL)I-8/NAP-1, MGSA/gro, IP-10 and 
PF-4, and the 13- or "C-C" subfamily that includes regu- 
lated on activation, normal T cell expressed and secreted 
(RANTES),  monocyte chemotactic protein  (MCP)-I,  2 
and 3, macrophage inflammatory protein-1 (MIP)-la and 
[3, and 1-309 among others (Schall and Bacon, 1994). Addi- 
tionally, it has recently been discovered lymphotactin, a 
new chemokine lacking two of the four cysteine character- 
istic residues, that represents a new branch in the chemokine 
family (Kelner et al., 1994). Platelets and a broad spectrum 
of nucleated cell types produce chemokines. Endothelial 
cells  are  an  important  source  of chemokines  like  IL-8, 
MGSA/gro, MCP-1, and IP-10. On the other hand, T lym- 
phocytes are also able to secrete IL-8, RANTES, MIP-la 
and  13,  and  MCP-1  (Oppenheim  et al.,  1991;  Woldemar 
Carr,  1994).  With  few exceptions, et-chemokines attract 
neutrophils, 13-chemokines attract monocytes, eosinophils, 
and/or basophils, and the members of both subfamilies to- 
gether with lymphotactin attract different subsets of lym- 
phocytes. It has been described that MIP-113 enhances the 
adhesion of CD8 ÷ T cells to vascular cell adhesion mole- 
cule-1 (VCAM-1) and fibronectin, and that RANTES, IP- 
10, MIP-let, and 13 increase the T  cell binding to human 
umbilical vein EC (Tanaka et al.,  1993a,  b, c; Taub et al., 
1993a, b; Gilat et al., 1994).  Chemokines produce their bi- 
ological effects by interacting with specific membrane re- 
ceptors that belong to the seven transmembrane spanning 
family of G-protein coupled receptors (Murphy, 1994). 
The interaction of lymphocyte function-associated anti- 
gen-1 (LFA-1) integrin with its ligands intercellular adhe- 
sion molecule (ICAM)-I, -2, and -3 is a regulated molecu- 
lar pathway that plays a  key role in T  cell adhesion to 
endothelium (Springer, 1990; Fawcett et al., 1992; Vazeux 
et al.,  1992; Campanero et al.,  1993; de Fougerolles et al., 
1992,  1993,  1994). ICAM-3  is the most abundant  LFA-1 
ligand on resting leukocytes, and it has been proposed as a 
pivotal molecule in the earliest phase of the immune re- 
sponse (Acevedo et al., 1993; Fawcett et al., 1992). The en- 
gagement of ICAM-3 triggers tyrosine phosphorylation of 
different substrates,  induces T  cell activation,  and  regu- 
lates the LFA-1/ICAM-1 and VLA-4/VCAM-1  adhesion 
pathways on T cells (Arroyo et al., 1994; Juan et al., 1994; 
Campanero et al.,  1993,  1994; Hern~indez-Caselles et al., 
1993).  The ligation of ICAM-3 by specific antibodies in- 
duces the development of a uropod structure on lympho- 
cytes, where ICAM-3 was almost exclusively concentrated 
(Campanero et al., 1994). 
CD43 and CD44 are other adhesion molecules that have 
also been implicated in lymphocyte stimulation. The CD44 
hyaluronate receptor is a broadly expressed glycoprotein 
involved in lymphocyte homing to peripheral lymph nodes, 
1. Abbreviations used in this paper: BIM If, bisindolylmaleimide II; EC, 
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kin; LFA-1, lymphocyte function-associated antigen-l; MCP, monocyte 
chemotactic protein;  MIP-1,  macrophage  inflammatory  protein-l;  PT, 
pertussis toxin;  RANTES,  regulated  on  activation,  normal  T  cell  ex- 
pressed and secreted; TIL, tumor infiltrating lymphocyte; VCAM-1, vas- 
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ceI1-ECM interactions, lymphocyte activation, and induction 
of homotypic cell aggregation (Aruffo et al., 1990; Koop- 
man et al., 1990). Similarly, CD43 or sialophorin is a heavily 
sialylated protein expressed by all leukocytes that partici- 
pates in leukocyte activation and aggregation (Nong et al., 
1989). 
In this report, we investigated the physiological mole- 
cules that are capable to trigger the formation of the cellu- 
lar uropod. We found that chemokines that are released 
during lymphocyte-endothelial cells (EC) interaction are 
responsible for the induction of both uropod formation in 
T  cells and  adhesion receptors (ICAM-1,  -3,  CD43,  and 
CD44) redistribution to this structure. The effect of each 
chemokine was selectively exerted on different T cell sub- 
sets,  and  appears  to  involve  G  proteins  and  a  cAMP- 
dependent signal transduction pathway. The relevance of 
these chemokine-regulated functional effects on lympho- 
cytes is discussed. 
Materials and Methods 
Antibodies,  Cytoidnes and Reagents 
The anti-ICAM-3 HP2/19  and TP1/24,  anti-CDlla TP1/40,  anti-VLA4 
HP2/1, anti-CD43 TP1/36,  anti-CD44 HP2/9, anti-CD45 D3/9,  anti-CD5 
TP1/21,  anti-CD7 MAR21, anti-CD4 HP2/6, and anti-CD8 B9.4.2  mAb 
have been described (Campanero et al., 1991, 1993; Pulido et al.,  1988, 
1991; Carrera et al., 1989). The anti-ICAM-1 MEM 111 was a generous 
gift of Dr. V. Horejsi (Institute of Molecular Genetics, Academy of Sci- 
ences of the Czech Republic, Videnska, Czech Republic). Recombinant 
human (rh) RANTES (specific activity 2-5 ×  103 U/mg, purity >97%, en- 
dotoxin level <0.1 ng/txg cytokine) and rhMIP-1 B (specific activity 1.6-2.5 
x  104 U/mg, purity >97%,  endotoxin level <0.1  ng/~g cytokine) were 
purchased from R&D Systems (Minneapolis, MN). rhlL-8 (purity >98%, 
endotoxin level <0.1  ng/Ixg cytokine), rhMCP-1 (purity >99%), rhMIP- 
la (purity >99%, endotoxin level <0.1 ng/ixg cytokine), rhTNF-a (spec. 
act. 5  ×  107 U/mg, purity >95%) was provided by Genetech (San Fran- 
cisco, CA), and IFN-y (spec. act. 2 × 107 U/mg, purity >98%, LPS content 
<0.048 ng/ml) was a gift from Amgen Biologicals (Thousand Oaks, CA). 
Prostaglandin E> 8-Bromoadenosine 3':5'-cyclic monophosphate (8-Br- 
cAMP), butanedione monoxime, colchicine, and cytochalasin D were pur- 
chased from Sigma Chemical Co.  (St. Louis, MO). Forskolin, pertussis 
toxin,  H-89  (N-[2-(p-bromocinnamylamino)ethyl]-5-isoquenilesulfona- 
mide), and bisindolylmaleimide II (BIM If) were from Calbiochem (San 
Diego, CA). 
Protein Substrata 
Recombinant chimeric ICAM-1-Fc and VCAM-1-4D-Fc, consisting of the 
total extracellular domains fused to IgG1 Fc fragment were obtained as 
described (Berendt et al., 1992; Fawcett et al., 1992). Briefly, COS-7 cells 
were  transiently  transfected  with  pICAM-1-Fc  and  pVCAM-1-4D-Fc 
(ICAM-1 and VCAM-1-4D cDNAs cloned in pCD8IgG1). After 4 d, cul- 
ture supernatants were precipitated with ammonium sulphate, and there- 
after  chimeric proteins  were  isolated  by  using  protein  A  coupled  to 
Sepharose (Pharmacia Fine Chemicals, Uppsala, Sweden). Recombinant 
soluble E-selectin was kindly provided by Dr.  R.  Lobb (Biogen, Cam- 
bridge, MA). The tryptic 38-kD and 80-kD fibronectin fragments (FN40 
and FN80) were a generous gift of Dr. A. Garcia-Pardo (Centro de Inves- 
tigaciones Biol6gicas, Madrid, Spain). Poly-L-lysine and fibrinogen were 
purchased from Sigma Chem. Co. (St. Louis, MO). Bovine serum albumin 
(BSA) was purchased from Boehringer Mannheim GmbH (Mannheim, 
Germany). 
Ce//s 
Human T  lymphoblasts were prepared from peripheral blood mononu- 
clear cells by treatment with phytohemagglutinin (PHA) 0.5% (Pharma- 
cia) for 48 h. Cells were washed and cultured in RPMI 1640 (Flow Lab., 
Irvine,  Scotland)  containing  10%  FCS  (Flow Lab.)  and  50  U/ml IL-2 
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typically used in all experiments. T  lymphoblasts and T  cell clones have 
been extensively used to study T cell adhesion and activation (Campanero 
et al., 1993). 
HSB-2 T lymphoblastoid cell line was kindly provided by Dr. N. Hogg 
(Imperial Cancer Research Fund, London), and has previously been de- 
scribed (Dougherty et al., 1988). 
CD4 ÷ and CD8 ÷ T  cells were prepared by exhaustive negative selec- 
tion from T lymphoblasts using anti-CD8 or anti-CD4 mAb, respectively, 
and immunomagnetic  beads (Dynal, Oslo, Norway) as described (Vartdal 
et  al.,  1987).  CD8 + tumor infiltrating lymphocytes (TIL)  were  isolated 
from melanoma specimens obtained from the Department of Pathology, 
Hospital  de  la  Princesa  (Madrid,  Spain).  These cells were  cultured  in 
AIM-V medium (Flow Lab.) containing 10% HY-ultroser serum (Phar- 
macia) and 5,000 U/ml IL-2. 
Human umbilical vein endothelial cells (HUVEC)  were  obtained as 
described  (Dejana et al.,  1987).  Briefly, umbilical vein was cannulated, 
washed, and incubated with 0.1% collagenase P (Boehringer) for 20 min 
at 37°C. Cells were seeded into flasks and cultured in M199 medium (Flow 
Lab.) supplemented with 20% FCS, 50 p,g/ml endothelial cell growth sup- 
plement, and 100 ixg/ml heparin (Sigma). Cells within two passages were 
used. 
Immunofluorescence  Analysis 
Immunofluorescence  experiments  were  performed  essentially  as  de- 
scribed (S~inchez-Mateos et al.,  1993).  Briefly, 2  x  106 T  lymphoblasts 
were  incubated  in  flat-bottomed,  24-well  plates  (Costar  Corp.,  Cam- 
bridge, MA) in a final volume of 500 Ixl complete medium on coverslips 
coated with different protein substrata. In some experiments, coverslips in 
that HUVEC were grown and stimulated with TNF-ct (10 ng/ml for 16 h at 
37°C) were used. Chemokines and other cytokines at different concentra- 
tions, or 5 p,g/ml HP2/19 mAb were added and cells were allowed to settle 
in a cell incubator at 37°C and 5 % CO2 atmosphere. After different peri- 
ods of time cells were fixed with 3.7% formaldehyde in PBS for 10 min at 
room temperature and rinsed in TBS (50 mM Tris-HC1, pH 7.6,  150 mM 
NaC1, 0.1% NAN3). To visualize different membrane adhesion molecules, 
cells were stained with specific mAb. After washing, cells were incubated 
with a  1:50 dilution of an FITC-labeled rabbit  F(ab')2 anti-mouse IgG 
(Pierce, Rockford, IL). For double-label studies in lymphocyte/EC cocul- 
tures, cells were  saturated with  10%  nonspecific mouse serum in TBS. 
Then, the coverslips were incubated with biotinylated mAb to other pro- 
tein, followed by washing and labeling with TRITC-avidin D (Vector Lab- 
oratories, Inc., Burlingame, CA) for 30 min, washed with TBS and incu- 
bated  with  a  biotinylated  anti-avidin  (Vector  Labs.,  Inc.)  for  30  min. 
Finally, a  fourth incubation with TRITC-avidin D  for 30 min was done. 
The cells were observed using a Nikon Labophot-2 photomicroscope with 
40, 60, and 100  x  oil immersion objectives. The proportion  of uropod- 
bearing cells was calculated by random choice of ten different fields (60 x 
objective) of each condition and direct counting of total cells (400-500) 
and uropod-bearing cells. Preparations were photographed on either ek- 
tacbrome  400  (color  pictures)  or  TMAX  400  (black  and  white)  film 
(Kodak). The latter was processed to 800-1600 ASA with TMAX devel- 
oper (Kodak). Where indicated, red and green fluorescence was photo- 
graphed on the same frame and, in some cases, we were compelled to 
move the focus in order to show both colors in focus. 
Cell Adhesion Assays 
Adhesion assays were essentially performed as previously described (Ar- 
royo et al., 1992).  Briefly, 50 ixl/well of 20 mM Tris-HC1, pH 8.0, contain- 
ing FNS0 or recombinant chimeric ICAM-1-Fc, were used to coat 96-well 
microtiter EIA II-Linbro plates (Costar Corp.) for 2 h at 37°C,  and then 
saturated with PBS containing 1%  HSA for 30 min at 37°C.  Thereafter, 
plates were washed with PBS and 3 x  105 T lymphoblasts per well in 100 
mxl were added and centrifuged for 5 min at 10 g before an incubation at 
37°C for 20 min. To quantify cell attachment, the plates were washed with 
RPMI containing 0.5% HSA, and cells were fixed with a mixture of ace- 
tone/methanol 1:1 and stained with violet crystal 0.5%. Violet crystal was 
then extracted by the addition of a 1:1 mixture of sodium citrate 0.1 M, pH 
4.2/ethanol, and absorbance at 540 nm was measured in an ELISA reader 
(LP400,  Kallestad, Chaska, MN).  For  inhibition assays, cells were pre- 
treated with different pharmacological agents for 30 min at 37°C. 
Aggregation Assays 
Homotypic cell aggregation was performed as previously described (Cam- 
panero et al., 1993).  Briefly, T lymphoblasts were incubated by duplicate 
in flat-bottomed, 96-well microtiter plates (Costar Corp.) at 1.5 x  106/ml 
in a final volume of 100  p.l of complete medium. Anti-ICAM-3 HP2/19 
mAb was added at 1 I~g/ml and cells were allowed to settle in an incubator 
at 37°C and 5% CO2 atmosphere. Cell aggregation was determined at dif- 
ferent periods of time by direct visualization of the plate with an inverted 
microscope and counting the free cells of at least five randomly chosen ar- 
eas of 0.025  mm  2, delimited by a special grid placed under the plate. Re- 
suits were expressed as percent of aggregated cells. For inhibition assays, 
cells were pretreated with different pharmacological agents for 30 min at 
37°C before the addition of the inducing mAb. 
Results 
Chemokines Induce Uropod  Formation and ICAM-3 
Clustering in This Structure 
Cell polarization involves the development of a cytoplas- 
mic projection which is termed uropod. This structure is 
characteristic of migrating lymphocytes and is displayed in 
the back, as a pseudopod-like projection. The induction of 
a cellular uropod has previously been described on T lym- 
phoblasts adhering to either protein substrata  or TNFa- 
activated  HUVEC  upon  treatment  with  an  activatory 
anti-ICAM-3  mAb; the ICAM-3  adhesion molecule was 
preferentially localized to the most distal portion of the 
uropod (Campanero et al.,  1994).  Nevertheless, a signifi- 
cant  number  of uropodia-bearing cells was  observed in 
some experiments in the  absence of the activatory anti- 
ICAM-3 mAb. To ascertain this issue, we thoroughly in- 
vestigated the extent to which the interaction of T lympho- 
blasts with EC could elicit the formation of cell uropodia. 
To this end, HUVEC that were induced with TNF-a to ex- 
press ICAM-1 and VCAM-1 were cocultured with T lym- 
phoblasts during different periods of time. In these stud- 
ies,  we  have  confirmed  that  the  anti-ICAM-3  HP2/19 
mAb is a strong stimulus for uropod formation (Fig. 1 B); 
in addition, we have found that at early times of incuba- 
tion (30 min), and in the absence of stimulatory antibody, 
uropod formation may be  negligible  or not, mainly  de- 
pending  upon  cell  (lymphoblast  and  HUVEC)  donors. 
Thus, the generation of uropods where ICAM-3 was lo- 
cated could be observed as early as 30 min after culture 
(Fig. 1, A a, and B). However, the proportion of cells bear- 
ing uropodia significantly increased after 4 and 20 h of cul- 
ture (Fig.  1 B). Freshly isolated peripheral blood T  lym- 
phocytes did not generally display cellular uropods at 30 
min of culture, but comparable levels of cells bearing uro- 
pods than T lymphoblasts were observed after 20 h of in- 
cubation on EC (Fig. 1 B). When T lymphoblasts were si- 
multaneously stained for ICAM-3  and LFA-lct, the latter 
molecule showed a punctate cell distribution along all the 
contact area of T cells with endothelial cells (Fig. 1 A b). 
Numerous  soluble  mediators  are  released  during  the 
leukocyte-EC interaction. Chemokines are one of the im- 
portant locally secreted peptides that are able to induce 
chemotaxis of specific leukocyte subsets  (Oppenheim et 
al., 1991), and that play a key role in the regulation of the 
adhesive properties of leukocyte integrins (Tanaka et al., 
1993a, b, c). To explore whether chemokines are involved 
in the uropod formation in T cells during their interaction 
with HUVEC, we assayed the ability of a large panel of 
these  and other several cytokines to trigger the  appear- 
ance of this cellular structure. Immunofluorescence analy- 
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Figure 1.  Uropod formation and ICAM-3 redistribution during 
interaction of T lymphoblasts with endothelial cells. (A) HUVEC 
were stimulated with 10 ng/ml TNF-c~ for 16 h at 37°C. T lympho- 
blasts were allowed to bind to coverslips coated with these cells 
for 30 min. Then, fixed cells were double stained for ICAM-3 (a) 
and  LFA-1  (b)  as described in  Materials and  Methods.  Same 
fields were  photographed  under  epifluorescent (a  and  b)  and 
bright field (c) conditions. (B) Freshly isolated peripheral blood 
T lymphocytes and T lymphoblasts were cultured with EC in the 
presence or in the absence of 1 txg/ml anti-ICAM-3 HP2/19 for 
30 min, 4 h, or 20 h, and the percentage of ICAM-3  ÷ cells bearing 
uropod was quantified as described in Materials and Methods. 
Arithmetic mean  ---1 SD of five independent experiments with 
freshly isolated T cells and T lymphoblasts from ten different do- 
nors, are shown. 
ses  were  carried  out  with  T  lymphoblasts that  were  in- 
duced  to  interact  with  immobilized  ICAM-1,  in  the 
presence of different cytokines. Interestingly, when T  cells 
were stimulated with the  chemokines RANTES,  MCP-1, 
and, to a  lesser extent, with IL-8 and MIP-113, the uropod 
formation and the ICAM-3 redistribution to this structure 
were clearly appreciated (Fig. 2, A-D). This effect was ob- 
served over a range of chemokine concentrations from 0.1 
to  100  ng/ml, but maximal uropod induction was exerted 
within the range of 10-50 ng/ml (Fig. 3 A). Kinetics studies 
revealed that chemokine-mediated uropod formation was 
very rapid, starting at 5  min, and declining after 4-6 h  of 
chemokine stimulation (Fig. 3 B). In contrast, the cytokines 
IFN-'y, TNF-et, and IL-2, at the doses assayed, were unable 
to induce the appearance of the uropod and the redistribu- 
tion of ICAM-3 (Fig. 2 E, and Fig. 3). Furthermore, other 
stimuli for T  cells like phorbol esters, also failed to induce 
those  phenomena  (not  shown).  The  stimulatory  anti- 
ICAM-3 HP2/19 mAb was used as control for triggering of 
uropod formation (Fig. 2 F, and Fig. 3 B). 
The Journal of Cell Biology, Volume 131,  1995  498 Figure 2.  Chemokines induce uropod formation and ICAM-3 redistribution during T lymphoblast attachment to ICAM-1. T lympho- 
blasts were allowed to bind to coverslips coated with 20 I~g/ml  ICAM-1-Fc for 30 min at 37°C in the presence of 10 ng/ml RANTES (A), 
MCP-1 (B), MIP-113 (C), IL-8 (D), IFN-'y (E), or 5 ~g/ml anti-ICAM-3 HP2/19 mAb (F). Then, fixed cells were stained for ICAM-3 
with TP1/24 mAb as described in Materials and Methods. The cellular uropod and the cell contact area with the substratum were indeed 
in a distinct plane of focus. Arrows have been added to indicate the cell bodies. 
We  next  examined  the  ability  of  the  chemokines 
RANTES and MCP-1 to induce cell polarization on other 
substrates such as VCAM-1, or the fibronectin fragments 
FN40 and FN80, that contain binding sites for very late ac- 
tivation antigen (VLA)-4 and VLA-5. Interestingly, these 
two  chemokines were  able  to  trigger  uropod  formation 
and ICAM-3 redistribution in lymphoblasts incubated on 
ICAM-1, VCAM-1, and FN80, and in a  lower extent on 
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Figure 3.  Dose dependence and kinetics of the uropod formation effect induced by chemokines. T lymphoblasts were allowed to bind to 
coverslips coated with 20 Ixg/ml ICAM-1 (A and B) or FN80 (C and D) in the presence of several doses of the different chemokines and 
cytokines for 30 min (A and C) and for different times of incubation with cytokines at 10 ng/ml or 50 U/ml IL-2 (B and D). As control, 
cells treated with 5 ixg/ml anti-ICAM-3 HP2/19 mAb and untreated were also included in time course experiments. Then, fixed cells 
were stained for ICAM-3 and the percentage of uropod-bearing cells was quantified as described in Materials and Methods. A represen- 
tative experiment, out of five independent ones" on each substrate and performed with T lymphoblasts obtained from different normal 
donors, is shown. 
the  38-kD  FN  fragment containing  CS-1  (Fig.  4).  Dose- 
response  and  time-course  studies  performed  on  FN80 
yielded  similar  results  to  those  obtained  with  ICAM-1 
(Fig. 3,  C  and D). In contrast, these chemokines did not 
trigger uropod formation when T  blasts were settled  on 
E-selectin, poly-L-lysine, BSA, or fibrinogen (Fig. 4, and 
data  not  shown).  Under  these  conditions,  ICAM-3  dis- 
played a uniform distribution over the rounded surface of 
the cell. 
Other adhesion molecules and leukocyte cell surface an- 
tigens were also tested for their ability to redistribute to- 
wards the uropod, on T cells induced to adhere to FN80 in 
the  presence  of RANTES.  Very interestingly,  ICAM-1, 
was also found to localize in the uropod upon RANTES 
stimulation,  although  to .a  lower  extent  than  ICAM-3 
(over 15%  of the  cells)  (Fig.  5 A). Two other  adhesion 
molecules,  CD43  and  CD44,  were  also  localized  in  that 
structure in a small proportion (14-18%) of T  cells upon 
treatment with this chemokine (Fig. 5, B  and C). Double 
fluorescence studies showed that all these molecules colo- 
calized  in  the  same  cellular  uropod,  although  ICAM-1, 
CD43,  and CD44 were present in a  lower proportion of 
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Figure  4.  Chemokine-mediated  cellular  polarization  during  T 
lymphoblasts  adhesion  to  different  substrates.  T  lymphoblasts 
were allowed to bind to coverslips coated with either 20  txg/ml 
ICAM-1-Fc,  10  Ixg/ml  VCAM-1-Fc, 20  Ixg/ml  FN80,  20  txg/ml 
FN40, 20  ixg/ml rsE-selectin, or 100  ~g/ml poly-L-Lysine for 30 
min at 37°C either in the presence or in the absence of 10 ng/ml of 
RANTES or MCP-1. Coverslips were processed as described in 
Materials and Methods. Arithmetic mean  +_1  SD of three inde- 
pendent experiments are shown. 
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majority  of molecules  tested,  including  LFA-1,  131  inte- 
grins, CD45, CD3, CD2, CD7, and CD5, did not redistrib- 
ute  to  the  cellular  uropod,  (Fig.  5,  D-F,  and  data  not 
shown). 
Selective Uropod Induction by Chemokines in Different 
T Cell Subsets 
It has previously been described that different chemokines 
act as chemotactic factors for different T  cell subsets and/ 
Figure 5.  Redistribution of adhesion molecules to the cellular uropod upon chemokine treatment. T lymphoblasts were atlowed to ad- 
here to FN80-coated coverslips for 30 min at 37°C in the presence of 10 ng/ml RANTES. Then, fixed cells were stained for ICAM-1 (A), 
CD43 (B), CD44 (C), CD7 (D), LFA-lct (E), or CD45 (F) as described in Materials and Methods. Arrows have been added to indicate 
the cell uropods. 
del Pozo et al. Regulation of  Lymphocyte Polarization by Chemokines  501 or cells at different stages of differentiation. Therefore, it 
was of interest  to explore whether  different chemokines 
were  able to trigger uropod formation selectively in  the 
major mature T cell subsets. Whereas in CD4 ÷ cells the ef- 
fect was exerted mainly by RANTES, MIP-la, and MCP- 
1,  in  CD8 ÷  cells  MIP-113  displayed  the  highest  activity 
(Fig. 6). Furthermore, the effect of chemokines was also 
studied on CD8 ÷ tumor infiltrating lymphocytes (TIL) iso- 
lated  from  two  different  patients  with  melanoma.  We 
found  that  over 60%  of the  CD8  TIL showed  cellular 
uropodia where ICAM-3 was redistributed after treatment 
with  MIP-113,  whereas  little  effect  was  obtained  with 
RANTES  or  MIP-lo~, that  selectively targeted  CD4 ÷ T 
cells (Fig. 7 A). Interestingly, the long cytoplasmic projec- 
tions,  resembling neuronal  axons,  that  TIL displayed  in 
normal  culture,  tended  to  disappear  after  chemokine 
treatment (Fig. 7 B). 
Involvement of cAMP Signaling Pathway 
in Uropod Formation 
Chemokines bind to receptor molecules from the seven- 
transmembrane-domain  rhodopsin-like  family  expressed 
on various immune cells, that couple through G  proteins 
to adenylate cyclase (Murphy,  1994).  To examine the in- 
volvement of cAMP signaling pathway in uropod forma- 
tion, T cells were treated with pharmacological agents that 
increase intracellular levels of cAMP (PGE  2 and forsko- 
lin) and with 8-Br-cAMP, a membrane permeable cAMP 
analogue. All these reagents were able to induce uropod 
formation and ICAM-3 redistribution on T  lymphoblasts 
adhering to ICAM-1 (Fig. 8) or FN80 (not shown). More- 
over, they exerted an additive effect in combination with 
either RANTES and MCP-1, but not with the anti-ICAM- 
3 HP2/19 mAb (Fig. 8). However, an additive effect was 
indeed  observed between  suboptimal  doses of the  anti- 
ICAM-3 mAb and cAMP agonists (data not shown). Next, 
we examined whether the interference with cAMP signal- 
ing could affect the development of cell uropodia induced 
by chemokines and  anti-fCAM-3 mAb. To this end,  we 
treated  T  lymphoblasts  with  H-89  (N-[2-(p-bromocin- 
namylamino)ethyl]-5-isoquenilesulfonamide),  a  selective 
inhibitor  of cAMP-dependent  protein kinase  (Chijiwa et 
al.,  1990).  This  agent  prevented  uropod  formation  and 
ICAM-3 redistribution mediated by RANTES and MCP- 
1,  and  to a  lower extent by the  anti-ICAM-3  activating 
mAb (Fig. 9 A). No inhibitory effects of H-89 was exerted 
on T  lymphoblasts cell adhesion to FN80 (see below Fig. 
10 B) or ICAM-1-Fc (not shown). In contrast, the selective 
inhibitor of protein kinase C bisindolylmaleimide II (Toul- 
lec et al., 1991)  did not inhibit uropod formation. Further- 
more, this agent was able to induce by itself a certain level 
of uropod  formation  and  ICAM-3  redistribution  (Fig.  9 
A),  thus  suggesting  a  "cross-talk"  between  cAMP-  and 
PKC-dependent signaling pathways (Kozawa et al.,  1992; 
Zong et al., 1994). 
Most of the biological effects of chemokines are inhib- 
ited by pertussis toxin (PT), a specific inhibitor of certain 
G  proteins, although a small PT-resistant component can 
usually be detected (Wu et al., 1993; Murphy, 1994; Mag- 
hazachi  et  al.,  1994).  To examine the  involvement of G 
proteins-dependent signaling in chemokine-mediated uro- 
pod formation, T cells were pretreated with PT, and then 
40 
CD3+ 
3O  + 
i 
~  20 
g 
5 
lO 
0 
50  CD4+ 
40 
"• 
30 
i: 
~"  zo 
10 
0 
50  CD8+ 
4O 
30 
~  20 
10 
Treatment:  None  RANTES MCP-1  MIP-lo  MIP-1B  L-8  IFN-~r 
Figure 6.  Selective uropod induction  by chemokines in different 
T cell subsets. CD3 ÷ (A), CD4 ÷ (B), or CD8 ÷ (C) T lymphoblasts 
obtained as described in Materials  and Methods were allowed to 
interact with ICAM-1-Fc-coated coverslips for 30 min at 37°C ei- 
ther untreated or in the presence of 10 ng/ml RANTES, MCP-1, 
MIP-lc~, MIP-113, IL-8, and IFN-~,; then fixed cells were stained 
for ICAM-3 and the proportion of cells bearing uropod was cal- 
culated as described above. Arithmetic mean -+1 SD of three in- 
dependent experiments are shown. 
allowed to interact with immobilized ICAM-1 in the pres- 
ence  of  either  RANTES,  MCP-1,  or  the  anti-ICAM-3 
mAb HP2/19. The raising of the uropod and the ICAM-3 
relocation  induced  by RANTES  and  MCP-1  was  com- 
pletely prevented by PT (Fig. 9 A). A similar inhibitory ef- 
fect of PT was observed over uropodia formation induced 
by MIP-let, MIP-I[3, and IL-8 (data not shown). However, 
the dose of PT employed (1 p+g/ml) induced an incomplete 
inhibition  of the  uropod formation by the  anti-ICAM-3 
mAb (Fig. 9 A); a high dose of PT (2 ~g/ml) completely 
abrogated uropod formation induced by this antibody. In- 
The Journal of Cell Biology, Volume 131, 1995  502 A 
75  TIL  CDS+ 
60  t- 
O 
U  ..q 
-o  45 
_= 
'qD 
O 
,-,  3O 
O 
N  15 
0 
Treetment:  None  RANTESMCP-1 MIP-la MIP-1B  IL-8  TNF-a 
Figure 7.  Uropod induction by chemokines in CD8 ÷ TIL. CD8 + 
TIL were allowed to bind to coverslips coated with ICAM-1-Fc 
for 30  min at 37°C  in the presence of RPMI  1640 or 10 ng/ml 
RANTES,  MCP-1,  MIP-lct,  MIP-1E3, IL-8,  or  TNF-a.  Then, 
ICAM-3-stained coverslips were processed as described in Mate- 
rials and Methods (A). In parallel, some cells treated with MIP- 
113 (b), or untreated (a) were photographed (B). Note the mor- 
phological changes of TIL after chemokine treatment. Arithmetic 
mean ± 1 SD of three separate experiments performed with TIL 
from two different patients are shown. 
terestingly, the addition of 8-Br-cAMP after PT treatment 
of T  lymphoblasts partially reverted the inhibitory effect 
of PT (Table I), indicating that PT has no irreversible ef- 
fect on T cells. No inhibitory effect of PT was exerted on T 
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Figure 8.  cAMP agonists induce uropod formation and ICAM-3 
redistribution during T  lymphoblasts attachment to ICAM-1. T 
lymphoblasts were incubated for 30 min at 37°C in the presence 
or in the absence of 2 txM PGE2, 50 ixM forskolin, or 1 mM 8-Br- 
cAMP,  and  then  allowed  to  bind  to  coverslips  coated  with 
ICAM-1-Fc for 30 min at 37°C, in the presence or in the absence 
of 10 ng/ml RANTES, MCP-1, or 5 txg/ml anti-ICAM-3 HP2/19 
mAb. Then, fixed cells were stained for ICAM-3 and the percent- 
age of cells bearing uropodia was measured as described in Mate- 
rials and Methods. Data represent mean values (-+SD) of five in- 
dependent experiments performed. 
lymphoblasts cell adhesion to FN80 (see below Fig. 10) or 
ICAM-1-Fc (not shown). 
Similar inhibition experiments were performed in the T 
lymphoblast-like cell line HSB-2 (Dougherty et al., 1988), 
which  also  bears  the  cytoplasmic uropod  when  the  cells 
are allowed to adhere to FN80 (not shown).  As it occurs 
with T  lymphoblasts, both PT and H-89 cAMP-dependent 
kinase inhibitor, but not bisindolylmaleimide II were able 
to abrogate uropod appearance in HSB-2 cells (Fig. 9 B). 
Role of Myosin in Uropod Formation 
and Cell Aggregation 
We  have  previously described the  presence  of linear ar- 
rays of myosin in cell uropods induced through ICAM-3, 
and the abrogation of this structure by the myosin-disrupt- 
ing drug butanedione monoxime (Campanero et al., 1994). 
To  explore  the  involvement  of the  myosin motor  in  the 
uropod  formation  induced  by chemokines,  we  used  this 
myosin-disrupting agent. As shown in Fig. 10, butanedione 
monoxime  completely  prevented  the  uropod  formation 
Table I. Reversion by 8-Br-cAMP of Pertussis Toxin Effect on 
Uropod Formation 
Pretreatment 
None  8-Br-cAMP  PT  PT + 
Simuli  8-Br-cAMP 
None  15  ±2  44±3  6-+  1  33±3 
HP2/19  54  -+ 5  79  -+ 4  25  ±- 2  51  ±  2 
T  lymphoblasts were incubated  for 30 min in the presence or in the absence of 1 ~g/ 
ml pertussis toxin, and then  1 mM 8-Br-cAMP was either added or not. After 30 rain, 
T cells were allowed to bind to coverslips coated with ICAM-1-Fc in the presence or 
in  the  absence  of  anti-lCAM-3  HP2/19  mAb.  Then,  fixed  cells  were  stained  for 
ICAM-3 and the percentage of cells bearing uropodia was calculated  as described in 
Materials  and  Methods.  Arithmetic  mean  -+ 1  SD  of two  separate  experiments  are 
shown. 
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Figure 9.  Pertussis toxin and the cAMP-dependent kinase selec- 
tive inhibitor H-89 prevent chemokines-mediated uropod forma- 
tion and ICAM-3 redistribution. T lymphoblasts (A) and HSB-2 
T cells (B) were incubated for 30 min at 37°C in the presence or 
absence of 1 i~g/ml pertussis toxin, 30 txM H-89, or 1 ixM bisin- 
dolylmaleimide II. Then, T  lymphoblasts (A) were  allowed to 
bind to coverslips coated with ICAM-1-Fc for 30 min at 37°C, in 
the presence or in the absence of 10 ng/ml RANTES, MCP-1, or 
5 I~g/ml anti-ICAM-3 HP2/19 mAb. HSB-2 cells were allowed to 
bind to coverslips coated with FN80 for 30 min at 37°C. Then, 
fixed cells were stained for ICAM-3 and the percentage of cells 
bearing uropodia was measured as described in Materials and 
Methods. Data represent mean values (-SD) of four indepen- 
dent experiments performed. 
and  ICAM-3  reorganization  induced  by  RANTES  and 
MCP-1,  whereas  disruption  of microtubules with  colchi- 
cine did not inhibit the uropod formation (not shown). We 
have also tested the role of butanedione monoxime on cell 
adhesion and cell aggregation induced by the anti-ICAM- 
3  mAb (Campanero et al., 1993,  1994).  Interestingly, bu- 
tanedione monoxime did not inhibit the induction of anti- 
ICAM-3-mediated cell adhesion to FN80 or ICAM-1 (Fig. 
10 B, and data not shown). The role of uropod formation 
and cell polarization in the acquisition of locomotor capac- 
ity was investigated through a cell aggregation assay. In this 
assay, cells locomote on a dish to contact each other form- 
ing cell aggregates. Cell aggregation was assayed in the pres- 
ence  of butanedione  monoxime,  and  although  this  drug 
did not affect cell adhesion (Fig. 10 B), it completely blocked 
anti-ICAM-3-mediated aggregation of T  cells settled on 
culture dishes (Fig. 11). Colchicine did neither inhibit uro- 
pod formation (data not shown)  nor cell aggregation in- 
duced by the activating anti-ICAM-3 mAb (Fig. 11). These 
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Figure 10.  Myosin-disrupting drug butanedione monoxime pre- 
vents uropod formation but does not affect cell adhesion. (A) T 
lymphoblasts were incubated for 30 min at 37°C in the presence 
or absence of 10 mM butanedione monoxime, and then allowed 
to bind to coverslips coated with ICAM-1-Fc for 30 min at 37°C. 
Then, fixed cells were stained for ICAM-3 and the percentage of 
cells bearing uropodia was measured as described in Materials 
and Methods. Arithmetic mean ±1 SD of four separate experi- 
ments are shown. (B) T lymphoblasts were incubated for 30 min 
at 37°C in the presence or in the absence of 10 mM butanedione 
monoxime, 20 txM colchicine, 20 IxM cytochalasin D, 1 i~g/ml PT, 
or 30 tzM H-89. Then, anti-ICAM-3 HP2/19 mAb-induced adhe- 
sion to microtiter wells coated with 20 Ixg/ml FN80 was assayed as 
previously described (Campanero et al., 1994). Arithmetic mean 
± 1 SD of five separate experiments run by duplicate are shown. 
Adhesion to albumin-coated wells was always lower than 0.12 op- 
tical density units. 
results suggest that myosin motor is required for cell po- 
larization and aggregation but not for cell adhesion. 
Discussion 
It  has  been  described  that  upon  lymphocyte  activation, 
cells become  polarized, displaying a  uropod  (Wilkinson 
and Higgins, 1987). Lymphocyte polarization with the gen- 
eration of cell uropod and ICAM-3 redistribution to this 
structure takes place during the interaction of T-lympho- 
blasts with endothelial cells, and under stimulation with an 
anti-ICAM-3 mAb (Campanero et al., 1994). Interestingly 
enough, we report herein that several chemokines are effi- 
cient physiologic triggers of uropod formation and ICAM- 
3, ICAM-1, CD43  and CD44  redistribution when  T  lym- 
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Figure 11.  Myosin disruption inhibits ICAM-3-mediated  cell ag- 
gregation. T lymphoblasts were incubated for 30 rain at 37°C in 
the presence or in the absence of 10 mM butanedione monoxime, 
or 20 ixM colchicine, before the addition of anti-ICAM-3  HP2/19 
mAb. Percent of aggregation was calculated as described in Ma- 
terials and Methods, at different times from the beginning of the 
assay. Data are representative of six experiments. 
phocytes adhered to either endothelial cell adhesion mole- 
cules (VCAM-1, ICAM-1) or ECM proteins (fibronectin). 
We have confirmed that in absence of stimulatory anti- 
body, only a small and variable proportion of T  lympho- 
blasts spontaneously display cellular uropods and ICAM-3 
redistribution, and that the frequency of these phenomena 
is dramatically increased after the prolonged interaction of 
T cells with EC. This is in accordance with a previous re- 
port describing the formation of a T cell pseudopod where 
other adhesion molecules (namely CD2, CD44, and L-selec- 
tin) were polarized during coculture of lymphocytes and 
EC (Rosenman et al.,  1993).  Both endothelial and T cells 
are  able  to  secrete  a  large  array of chemokines during 
their  interaction or  upon  specific activation with  proin- 
flammatory stimuli (Oppenheim et al., 1991). Thus, the lo- 
cal production of chemokines may account for the uropod 
formation and adhesion receptor redistribution observed 
during lymphocyte-EC adhesion. This phenomenon could 
also explain the presence of uropodia and ICAM-3 redis- 
tribution in some isolated T lymphoblasts induced by PHA. 
ICAM-1, another ligand for LFA-1, was also driven to 
the cellular uropod upon T  lymphocyte stimulation with 
chemokines, although in a lower proportion of cells than 
ICAM-3.  This  is  in  agreement  with  a  previous  report 
where ICAM-1 redistribution to an uropod-like structure 
was detected on B lymphoblastoid cells that were interact- 
ing with LFA-l-coated surfaces (Dustin et al.,  1992), as 
well  as  on  cytospin  preparations  of T  and  B  cell  lines 
(Dougherty et al.,  1988;  Carp6n et al.,  1992).  Two other 
lymphocyte adhesion  molecules,  CD43  and  CD44  were 
also found to be redistributed to the cellular uropod upon 
chemokine  treatment.  These  two  glycoproteins  share 
some features with  ICAM-3,  such as their abundant  ex- 
pression on leukocytes, high glycosilation and involvement 
in leukocyte activation and aggregation. The location of all 
these  adhesion  receptors  within  the  uropod  supports  a 
possible proadhesive role of this cellular structure. An al- 
ternative possibility is that the induced surface redistribu- 
tion of these highly charged molecules to a cellular uropod 
may be part of a regulatory mechanism controlling the dis- 
tribution of surface charges. Therefore, the recruitment of 
highly glycosylated molecules to the  uropod, could dra- 
matically modify the negative charge distribution of lym- 
phocyte membrane, which might be accompanied by re- 
duced repulsion in the area of cell adhesion. In agreement 
with this hypothesis, it has been reported that CD43 may 
have an anti-adhesive function (Ardman et al., 1992; Man- 
junath et al.,  1993).  However, other highly charged mole- 
cules as CD45 did not redistribute to the cellular uropod. 
On the other hand, the redistribution of certain molecules 
within the uropod could be part of a multi-step regulatory 
system of lymphocyte adhesiveness: first, the physiological 
stimuli, that could be the interaction with a natural ligand 
plus other factors as chemokines, would elicit a rapid ad- 
hesion  receptor redistribution  towards  the  uropod;  sec- 
ond, sustained stimulation might lead to proteolytic cleav- 
age  of  those  molecules.  In  this  regard,  the  different 
molecules found herein to redistribute to the cellular uro- 
pod have been described that,  under certain conditions, 
are proteolytically cleaved and shed to the external milieu 
(Campanero et al., 1991; Del Pozo et al., 1994; Bazil et al., 
1995). 
Cell  adhesion  to  specific  integrin  ligands,  namely 
ICAM-1,  VCAM-1,  or  FN,  appears  to  be  required  for 
chemokine-mediated uropod induction, since mere physi- 
cal adhesion of lymphocytes to poly-L-lysine is not suffi- 
cient for triggering uropod formation in the presence of 
chemokines. On the other hand, stimuli capable to induce 
cell  spreading  such  as  PMA  or  anti-J31 integrin  TS2/16 
mAb,  fail to  trigger cellular uropod  (Campanero  et  al., 
1994).  Therefore, cell adhesion to integrin ligands seems 
to be an obligatory but not sufficient requirement in the 
induction of lymphocyte uropod by chemokines. Interest- 
ingly, uropod induction and cell adhesion appear to be in- 
dependently regulated, since they display different cytoplas- 
mic requirements. Our findings with a myosin-disrupting 
drug suggest that the force generated by the contraction of 
myosin  can  drive  both  cell  polarization  and  ICAM-3- 
induced cell aggregation, whereas the ICAM-3 induction 
of cell adhesion is independently regulated. 
G proteins couple seven-transmembrane domain recep- 
tors to enzymatic systems like adenylate cyclase and phos- 
pholipase C (Wu et al., 1993; Murphy, 1994; Mantel et al., 
1995).  cAMP-dependent pathway appears to be involved 
in the mobility of human T lymphocyte surface molecules 
(Kammer et al.,  1988).  On the other hand, it has recently 
been described that MIP-lct induces an increase in intra- 
cellular cAMP level in the megakaryocytic leukemia cell 
line M07e (Mantel et al., 1995). Therefore, we assessed the 
possible  implication of cAMP  signaling pathways in the 
regulation of uropod formation and cell adhesion receptor 
redistribution.  Our  results  that  a  membrane-permeable 
cAMP synthetic analogue as well as other different upreg- 
ulators of cAMP induce these cellular events, underscore 
the role of cAMP metabolism in the regulation of these 
phenomena. This is further supported by the prevention of 
either chemokine- or ICAM-3-induced uropod formation 
by H-89, an inhibitor of cAMP-dependent protein kinase. 
The cytoskeletal association of all of the adhesion mole- 
cules redistributed (Carp6n et al., 1992; Campanero et al., 
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war et al., 1994) along with the ability of cAMP-dependent 
kinase  to  trigger  cytoskeletal  protein  phosphorylation 
(Selden and Pollard, 1983; Kammer et al., 1988) suggest a 
possible  linkage.  Nevertheless, this issue deserves a  fur- 
ther understanding of the signal transduction mechanisms 
associated with chemokine-mediated uropod formation. 
Chemokines-directed  ICAM-3  redistribution  requires 
the coupling of the G-protein signaling pathway, as sug- 
gested by their inhibition with PT. In this context, other 
functions induced by chemokines such as leukocyte chemo- 
taxis (Spangrude et al., 1985), or firm adhesion (arrest) and 
migration of lymphocytes across EC (Bargatze and Butcher, 
1993) have also been found to be dependent on this path- 
way,  as  they are  blocked by PT.  Interestingly, we  have 
found that PT also blocks uropod formation induced by 
the  activating anti-ICAM-3  mAb.  This is in  accordance 
with results recently described showing that production of 
cAMP is sensitive to PT (Pian and Dobbs,  1995).  These 
data  along  with  the  inhibition  of uropod  formation in- 
duced by anti-ICAM-3 mAb with H-89, strongly suggest 
the involvement of G-protein and cAMP-dependent path- 
way in ICAM-3 signaling. This is not an astonishing find- 
ing since it has been described that other adhesion recep- 
tors  such  as  CD2  are  also  linked  to  cAMP-dependent 
signaling (Carrera et al.,  1988; Kammer et al., 1988; Hahn 
et al., 1991). This interesting point deserves further investi- 
gation. 
The precise cell subset that is targeted by each chemo- 
kine is still in dispute, specially in the case of MIP-la and 
MIP-I[3 (Tanaka et al.,  1993a; Taub et al.,  1993a,b;  Schall 
et al., 1993). Moreover, it has been described that a chemo- 
kine can attract at different concentrations different lym- 
phocyte  subsets  (e.g.,  MIP-la  for  CD8 ÷  and  CD4 ÷  T 
cells).  On the other hand, RANTES and MCP-1 [3-chemo- 
kines attract selectively memory T cells, T helper lympho- 
cytes in  the  case of RANTES  (Schall et al.,  1990), and 
both  helper  and  cytotoxic  T  cells  in  that  of  MCP-1 
(Woldemar Carr et al.,  1994).  Interestingly, lymphocytes 
that are recruited into inflamed tissues bear preferentially 
the  memory/activated  CD45RA-  CD45RO +  phenotype 
(Woldemar  Carr  et  al.,  1994).  Since  we  found  that  the 
chemokines RANTES and MCP-1 displayed the stronger 
capability in inducing uropods, it is feasible that this struc- 
ture is involved in the recruitment and migration of mem- 
ory T cells in vivo. MIP-I[3 showed little or no uropod in- 
ducing-effect over the CD4 ÷ T  cell population; however, 
its effect was very strong over the CD8 + T cells, isolated 
both from normal donors and from melanoma tumor infil- 
trating lymphocytes. The cellular uropod induced in TIL 
by chemokines may play an important role in vivo, acting 
as a recruiting structure to trap more CD8 ÷ T cells that, in 
turn, will be cytotoxic for tumor ceils. 
It has been proposed that chemokines exert their effects 
either as soluble/diffusible mediators (chemotactic mecha- 
nism) or immobilized on a cell surface (haptotactic mecha- 
nism)  (Rot,  1993;  Springer,  1994).  Interestingly enough, 
we have found that chemokines are able to trigger uropod 
formation and  ICAM-3  redistribution  when  T  ceils  are 
bound  to  either  EC  adhesion  molecules  (ICAM-1  and 
VCAM-1)  or ECM proteins (FN proteolytic fragments). 
Thus, it is very feasible that uropod formation occurs in vivo, 
during the firm adhesion of lymphocytes to endothelium. 
The chemokine-mediated regulation of lymphocyte mor- 
phology  and  redistribution  of  leukocyte  receptors  like 
ICAMs, CD43, and CD44, may represent a novel mecha- 
nism contributing to the recruitment of leukocytes to in- 
flammatory sites. In this model, chemokines would attract 
different leukocyte subsets  which  would  be  tethered by 
endothelial  selectins.  Chemokines  would  then  trigger 
functional activation of leukocyte integrins, which mediate 
strong adhesion to endothelium through their interaction 
with their counter-receptors ICAM-1,  -2,  and VCAM-1. 
Then, leukocytes would spread on the endothelial cell sur- 
face, and at the same time the cellular uropod induced by 
the chemokines would emerge towards the lumen of the 
vessel. In this structure, the high amount of ICAM-1, -3, 
and likely other molecules with similar features, would fa- 
cilitate the adhesion, recruitment, and activation of new 
passing leukocytes. Accordingly, a  good exposure of the 
L-selectin on neutrophils or the local clustering of the 132 
integrin Mac-1 or its ligand iC3b have been shown to facil- 
itate the intercellular interaction (Picker et al.,  1991; Det- 
mers et al.,  1987; Hermanowski-Vosatka et al.,  1988).  In 
addition, the activated T cells bound to EC, would secrete 
more chemokines, resulting,  all  the  above, in  a  positive 
feed back  loop that could significantly reinforce the  in- 
flammatory  response.  Therefore,  the  redistribution  of 
ICAM-3 and other adhesion receptors on the uropod may 
represent an amplifier mechanism  of a  chemotactic cas- 
cade initiated by chemokines. 
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